Article
Insulin resistance impairs sustained virological response rate to pegylated interferon plus ribavirin in HIV-hepatitis C virus-coinfected patients: HOMAVIC-ANRS HC02 Study.
Antiviral therapy - 1 Jan 2009
Cacoub Patrice, Carrat Fabrice, Bédossa Pierre, Lambert Jérôme, Pénaranda Guillaume, Pol Stanislas, Halfon Philippe
Abstract excerpt
BACKGROUND: The aim of this study was to assess the effect of insulin resistance (IR) on the response to hepatitis C virus (HCV) therapy in HIV-HCV-coinfected patients. METHODS: A total of 238 HIV-HCV-coinfected patients (74% male, mean +/-sd age 40 +/-5 years, mean alcohol intake <50 g/day and 38% HCV genotype 2 or 3), treated by standard or pegylated interferon-alpha2b plus ribavirin during 48 weeks were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
